Provided by Tiger Fintech (Singapore) Pte. Ltd.

West Pharmaceutical

245.90
-1.9500-0.79%
Volume:213.17K
Turnover:52.62M
Market Cap:17.68B
PE:36.79
High:249.63
Open:249.63
Low:245.65
Close:247.85
52wk High:352.33
52wk Low:187.43
Shares:71.91M
Float Shares:71.41M
Volume Ratio:0.43
T/O Rate:0.30%
Dividend:0.84
Dividend Rate:0.34%
EPS(TTM):6.68
EPS(LYR):6.75
ROE:17.72%
ROA:10.53%
PB:6.04
PE(LYR):36.43

Loading ...

Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 26, 2024

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
Jun 26, 2024

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
May 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Oct 27, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Sep 22, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities